Press Release – Vandalia, Ohio
Jan 29, 2007
iMDs (Innovative
Medical Device Sourcing) formed with merger of MedicineLodge, Inc.
and Leis Medical, Inc.
Logan, UT, and Vandalia, OH, January 29, 2007 - - MedicineLodge,
Inc. and Leis Medical, Inc. announced the completion of a merger
that creates a comprehensive outsourcing solution for medical device
companies. iMDs, which has a particular focus on the orthopedics
industry, will offer customized sourcing services to provide
exceptional responsiveness at every stage of the product life cycle
– from idea to sale.
These customized sourcing services will be known as:
-
iMDs Co-InnovateTM – outsourced product
development and innovation services
-
iMDs Prototype - prototyping services for products
under development
-
iMDs Test - testing services for products under
development
-
iMDs Express - rapid turn-around manufacturing for
small lots and clinical validation lots
-
iMDs Launch - time-definite manufacturing to support new
product launches
-
iMDs Continuous Improvement - manufacturing of ongoing
sales replenishment
“By combining our two companies, we are uniquely positioned to
provide Product Life Cycle Sourcing™ for our medical device
customers.
MedicineLodge’s proven ability to innovate and rapidly develop new
products that improve patient outcomes and Leis Medical’s recognized
position as a leading supplier of surgical implants and instruments
creates an incredible value proposition for our customers” stated
Wade Fallin, who will serve as President and CEO of iMDs.
Harold Linville, the new Chairman of iMDs and the former CEO of
Leis Medical states that “turnkey sourcing of new product lines,
from new concept innovation through product sales, provides our
customers with very attractive cost efficiencies and accelerated
time to market. This will allow our customers to bring additional
new products to market each year that can produce incremental sales
and help them gain market share.”
“The core competencies of the two companies are exceptionally
complimentary” commented Jim Marden, a Managing Director of Arsenal
Capital Partners. “We believe iMDs will ultimately help reduce the
number of supply chain vendors our OEM customers need to access and
accelerate the time required for new product introductions for large
medical device OEMs, venture-backed medical device companies, and
surgeons seeking a partner to help them take their ideas from
concept to reality.”
MedicineLodge,
Inc. was acquired by iMDs, which is controlled by the private equity
firm, Arsenal Capital Partners, who had previously acquired Leis
Medical. As a result of the acquisition, both MedicineLodge and
Leis Medical will be divisions of iMDs.
About
MedicineLodge, Inc.:
www.medicine-lodge.com
MedicineLodge, Inc. partners with physicians, venture capital firms
and corporations to develop medical devices that improve patient
outcomes. The company provides comprehensive product development
services and innovative technology solutions to the medical device
industry. Founded in 2000, the company employs approximately 70
people.
About
Leis Medical, Inc.:
www.leismedical.com
Leis
Medical is a world-class and global provider of orthopedic implants
and instrumentation servicing to the medical original equipment
manufacturer (OEM) industry. A manufacturer of medical devices for
more than 25 years, the company has recently experienced rapid
growth and is committed to making capital investments in technology
and personnel. Leis Medical is headquartered in Vandalia, Ohio, and
has sales offices in Winona Lake, IN and Memphis TN. Founded in
1950, the company employs approximately 200 people.
About Arsenal Capital Partners:
www.arsenalcapital.com
Arsenal Capital Partners is a New York-based private equity firm
that makes control investments in specialty manufacturing and
service companies. Arsenal invests in growing sectors where they
have knowledge and expertise, and in niche leaders that have the
potential for Arsenal and management to create additional value.
Arsenal focuses in the healthcare and specialty industrial sectors,
including medical devices, pharmaceuticals, specialty chemicals,
aerospace/defense, specialty components and distribution/logistics.
The firm currently has $800 million of committed equity capital.
For additional information on iMDs, please contact:
Wade
Fallin
435-753-7675
wfallin@imds.net
Source: MedicineLodge, Inc. and Leis Medical, Inc.
|